TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market
2025.5.6
...
Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau
2025.5.1
...
.jpg)
.jpg)
.jpg)
Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change
2025.3.24
...
.jpg)
TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities
2025.3.13
...
